文献速递肝病

肝硬化低钠血症:进展综述

Hyponatremia in Cirrhosis: An Update.
PubMed 文献 · Am J Gastroenterol · 2020-01-01

本综述阐述肝硬化腹水患者低钠血症的病理生理机制,包括内脏血管扩张激活肾素-血管紧张素-醛固酮系统、交感神经系统及抗利尿激素非渗透性分泌导致水潴留。传统治疗如限液和纠正低钾常无效,综述讨论白蛋白输注、选择性加压素受体拮抗剂及高渗盐水等治疗选择。

要点

  • 肝硬化腹水患者低钠血症源于内脏血管扩张激活代偿机制导致水潴留。
  • 抗利尿激素非渗透性分泌加重水潴留和低钠血症。
  • 传统限液和纠正低钾常无效,需考虑白蛋白、加压素受体拮抗剂或高渗盐水。

核心结论

  • 肝硬化低钠血症由内脏血管扩张激活RAAS、交感神经及ADH非渗透性分泌导致水潴留所致。
  • 传统治疗限液和纠正低钾常无效,需探索白蛋白输注、选择性加压素受体拮抗剂或高渗盐水等方案。

研究设计与样本

  • 综述,讨论肝硬化低钠血症的病理生理、并发症及治疗模式。

主要发现

  • 肝硬化进展和门脉高压导致内脏血管扩张,激活RAAS、交感神经和ADH以代偿低循环血量。
  • 净效应为钠水潴留,形成腹水,肾脏排自由水能力受损。
  • ADH非渗透性分泌加重水潴留和低钠血症。

临床怎么用

  • 对肝硬化腹水合并低钠血症患者,限液和纠正低钾常无效,可考虑白蛋白输注、选择性加压素受体拮抗剂或高渗盐水。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hyponatremia is frequently seen in patients with ascites secondary to advanced cirrhosis and portal hypertension. Although not apparent in the early stages of cirrhosis, the progression of cirrhosis and portal hypertension leads to splanchnic vasodilation, and this leads to the activation of compensatory mechanisms such as renin-angiotensin-aldosterone system (RAAS), sympathetic nervous system, and antidiuretic hormone (ADH) to ameliorate low circulatory volume. The net effect is the avid retention of sodium and water to compensate for the low effective circulatory volume, resulting in the development of ascites. These compensatory mechanisms lead to impairment of the kidneys to eliminate solute-free water in decompensated cirrhosis. Nonosmotic secretion of antidiuretic hormone (ADH), also known as arginine vasopressin, further worsens excess water retention and thereby hyponatremia. The management of hyponatremia in this setting is a challenge as conventional therapies for hyponatremia including fluid restriction and correction of hypokalemia are frequently inefficacious. In this review, we discuss the pathophysiology, complications, and various treatment modalities, including albumin infusion, selective vasopressin receptor antagonists, or hypertonic saline for patients with severe hyponatremia and those awaiting liver transplantation.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Alukal JJ, John S, Thuluvath PJ, et al. Hyponatremia in Cirrhosis: An Update. Am J Gastroenterol. 2020. PMID: 33156095. doi:10.14309/ajg.0000000000000786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。